Viewing nowGabamed Capsule 75 mg (Pregabalin)
Pregabalin 75mg
Hard capsule · Prescription medication
NBK Pharmaceuticals Co., Ltd.

MFDS item code 201800720 · Approved 2018.02.06 · Insurance code 054800090
Treatment of neuropathic pain, adjunctive treatment of partial seizures in epilepsy, and treatment of fibromyalgia
This medication is used to treat peripheral and central neuropathic pain in adults. It is also utilized as an adjunctive treatment for partial seizures, with or without secondary generalization, in patients with epilepsy. Additionally, it helps alleviate symptoms of fibromyalgia. Overall, it is effective in improving the management of pain and neurological disorders.
This drug is administered orally, with or without food, in 2 divided doses per day of the total daily dose of pregabalin. 1. Neuropathic pain 1) Peripheral neuropathic pain Adults: This drug may be administered at an initial dose of 150 mg per day. Based on each patient's response and tolerability, the dose may be increased to 300 mg per day after 3 to 7 days. If needed, it may subsequently be increased at 7-day intervals to a maximum of 600 mg per day. 2) Central neuropathic pain Adults: This drug may be administered at an initial dose of 150 mg per day. Based on each patient's response and tolerability, the dose may be increased to 300 mg per day after 1 week. After an additional week, it may be increased to the target daily dose of 600 mg. If the target daily dose is not tolerated, a dose reduction may be considered. 2. Epilepsy Adults: This drug may be administered at an initial dose of 150 mg per day. Based on each patient's response and tolerability, the dose may be increased to 300 mg per day after 1 week. If needed, it may subsequently be increased at 7-day intervals to a maximum of 600 mg per day. 3. Fibromyalgia The recommended dose of this drug for fibromyalgia is 300 mg ~ 450 mg per day. The initial dose is 75 mg twice daily (150 mg per day), and based on efficacy and tolerability, it may be increased within 1 week to 150 mg twice daily (300 mg per day). For patients who do not experience sufficient benefit at a dose of 300 mg per day, the dose may be increased within 1 week to 225 mg twice daily (450 mg per day). Clinical studies have also been conducted at a dose of 600 mg per day, but there is no evidence of additional benefit or adequate tolerability at this dose. In view of dose-dependent adverse reactions, doses exceeding 450 mg per day are not recommended. 4. Discontinuation of treatment Based on current clinical experience, if treatment with this drug is discontinued, it should be tapered gradually over at least 1 week. 5. Patients with renal impairment Since the clearance of this drug is directly affected by creatinine clearance, dose reduction in patients with impaired renal function should be individualized based on creatinine clearance. This drug is effectively removed from plasma by hemodialysis (approximately 50% within 4 hours). In patients undergoing hemodialysis, the daily dose of pregabalin should be adjusted based on renal function. In addition to the daily dose based on renal function, an immediate supplemental dose should be administered after each 4-hour hemodialysis session.
This medication may increase the risk of suicidal thoughts or behaviors, so any signs of depression or mood changes during treatment should be reported to a healthcare professional immediately. Patients allergic to any components of this medication or those with lactose intolerance should not take it. Diabetic patients may need to adjust the dosage of their blood sugar-controlling medications due to weight gain after taking this medication. If signs of allergic reactions such as angioedema occur, the medication should be discontinued immediately. Elderly patients should be cautious as dizziness or drowsiness may increase; if such symptoms occur, attention should be given to their activities. Transient visual disturbances or changes in vision may occur, so if unusual symptoms appear, consultation with a healthcare professional is advised. Sudden discontinuation of this medication can lead to withdrawal symptoms including insomnia, headache, and anxiety, so it should be tapering off under medical supervision. Due to the risk of drug abuse, patients with a history of substance abuse should be particularly cautious and report any abnormal behaviors to their healthcare provider. Patients with impaired kidney function may require dosage adjustments. Patients with cardiovascular disease need to be cautious when taking this medication. When taken in conjunction with opioid analgesics, there is an increased risk of central nervous system depression, so caution is advised. Patients with compromised respiratory function or elderly patients may face a risk of severe respiratory depression; dosage adjustments should be discussed with their healthcare provider. In early pregnancy, there is a risk of fetal malformations, so it is generally advised that pregnant women do not take this medication, and women of childbearing age should use effective contraception. Breastfeeding women should consider that this medication can be transferred into breast milk, and may need to discontinue breastfeeding or the medication. This medication can cause dizziness and drowsiness, so activities such as driving or operating machinery should be avoided until these symptoms completely resolve. Severe skin reactions can rarely occur; if symptoms such as skin rash or mucosal abnormalities arise, discontinuation of the drug should occur immediately and consultation with a healthcare professional should be made. In case of overdose, changes in mental state and seizures may occur, requiring immediate emergency treatment, and hemodialysis may be performed if necessary. Keep the medication out of the reach of children and do not transfer it to another container.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture, ideally at room temperature between 15 and 30 degrees Celsius. This helps maintain the effectiveness and safety of the medication.
A hard capsule with a reddish brown upper part and a white lower part filled with white powder.
30 capsules/bottle, 60 capsules/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPregabalin 75mg
Hard capsule · Prescription medication
NBK Pharmaceuticals Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 300mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Hanmi Pharm. Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.